Sun Pharma Leqselvi US launch, Leqselvi alopecia areata, Leqselvi deuruxolitinib

Sun Pharma Launches Leqselvi in U.S. After Patent Settlement—New Alopecia Areata Treatment Targets $900M Market

A major update is here—Sun Pharmaceutical Industries, one of India’s largest drugmakers, has officially launched its much-awaited hair loss treatment Leqselvi™ (deuruxolitinib) 8 mg tablets in the U.S. This launch comes after the settlement of a patent infringement case with Delaware-based Incyte Corporation. Sun Pharma Leqselvi US launch is expected to make waves in the […]

Zen Technologies patent victory, Zen Technologies IP dispute

Zen Technologies Wins Historic Patent Challenge in India, Strengthening Its Intellectual Property Protection

In a recent development, Zen Technologies Limited has won an important legal battle in the field of intellectual property rights (IPR). Zen Technologies patent victory is a major legal battle by challenging and canceling a patent that had been granted to people linked with MAG5 Innovations Private Limited on August 6, 2025. The disputed patent, […]

GSK and CureVac patent dispute

GSK to Receive $320 Million as BioNTech and Pfizer Settle mRNA Patent Dispute with CureVac

One of the biggest developments in the ongoing mRNA patent dispute has arrived—GSK will receive $320 million following a settlement between the BioNTech, CureVac, and Pfizer dispute. The agreement, reached after BioNTech and Pfizer chose to end a high-profile legal battle with the German biotech CureVac, closes a multi-year dispute over mRNA vaccine technology. The […]